The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine중증 급성 호흡기 증후군 코로나바이러스 2 메신저 RNA 백신 후 항체 지속성에 대한 이전 감염 및 연령의 영향Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] 19 2 acute respiratory syndrome affected age Antibody Response booster coronavirus coronavirus 2 CoV COVID Critical Determining environmental factor Genetic Immunity immunization Impact magnitude messenger Messenger RNA persistence respiratory RNA SARS SARS-CoV-2 SARS-COV-2 infection the antibody response the SARS-CoV-2 the timing vaccination Vaccine [DOI] 10.1093/cid/ciab850 PMC 바로가기 [Article Type] Article
Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York CityArticle Published on 2022-08-242022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 유전자 메커니즘, [키워드] acute respiratory syndrome B.1.617.2 Breakthrough infection breakthrough infections Cancer center characterization circulation clade clinical Clustering Cohort coronavirus coronavirus 2 death Delta dominant domination dose Effectiveness epidemiologic feature examined finding genomic hcp healthcare personnel Hospitalization Infection infections isolate laboratory-confirmed Messenger RNA moderate mRNA New York City occurred Post-vaccine respiratory Retrospective study SARS CoV-2 SARS-CoV-2 selection of variant Spread Strong study period Vaccine vaccine effectiveness variant WGS Whole genome sequencing [DOI] 10.1093/cid/ciab886 PMC 바로가기
Nanotechnology-based strategies against SARS-CoV-2 variants Reviews Published on 2022-08-182022-10-05 Journal: Nature nanotechnology [Category] COVID19(2023년), SARS, 변종, 신약개발, 임상, 치료제, [키워드] acute respiratory syndrome coronavirus coronavirus disease COVID-19 creating effective Efficacy immunological Infectious disease Messenger RNA mRNA vaccine Nanotechnology pandemic SARS-CoV-2 SARS-CoV-2 strain SARS-CoV-2 variant SARS-CoV-2 variants the SARS-CoV-2 Vaccine variant variants [DOI] 10.1038/s41565-022-01174-5 [Article Type] Reviews
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV 및 mRNA-1273을 사용한 SARS CoV-2에 대한 이종 면역의 면역원성과 반응성Article Published on 2022-08-162022-09-11 Journal: Cell Reports Medicine [Category] SARS, 변종, 진단, 치료기술, [키워드] Ad5-nCoV analyzed Anti-spike Antibody Response BBIBP-CorV ChAdOx1 ChAdOx1 vaccine ChAdOx1-S Cohort Combination coronavirus disease Coronavirus disease 2019 Coverage COVID-19 evaluate Heterologous heterologous vaccination heterologous vaccine highest homologous humoral Humoral response IgG immunization immunogenicity Immunoglobulin Immunoglobulin G information Messenger RNA mRNA mRNA-1273 nCoV Neutralizing antibodies observation observé omicron Omicron variant Participants platform provide reactogenicity Region SARS CoV-2 SARS-CoV-2 second dose Serious Adverse Event Serious Adverse Events Sputnik V Support titers vaccination Vaccine virus neutralizing titer virus neutralizing titers [DOI] 10.1016/j.xcrm.2022.100706 PMC 바로가기 [Article Type] Article
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity주산기 인간 면역결핍 바이러스에 감염된 청소년 및 젊은 성인은 뚜렷한 BNT162b2 메신저 RNA 코로나바이러스 질병 2019 백신 면역원성을 나타냅니다.Article Published on 2022-08-152022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adolescent anti-SARS-CoV-2 humoral antibody Antigen Antigen-specific T cells Antiretroviral therapy ART baseline BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine CD4+ T cell CD4+ T-cell CD40L Cellular responses characterized Cluster collected coronavirus coronavirus disease Coronavirus disease 2019 correlated COVID-19 demonstrated dose Efficacy eligibility evaluated expand feature Follow-up group HCs healthy control HIV HIV-infected patient HIV-infected patients Human Human immunodeficiency virus humoral immune response Immunity immunization immunodeficiency virus immunogenicity involved messenger Messenger RNA molecules mononuclear cell mononuclear cells mounted mRNA of BNT162b2 Olink perinatally HIV-infected patients. Peripheral blood Peripheral blood mononuclear cells plasma samples Population populations profile protein level protein levels proteomic proximity extension assay Regulation respiratory response responses RNA RNA coronavirus Safety Sample SARS-CoV-2 SARS-CoV-2 antibody second dose severe acute respiratory syndrome Coronavirus study groups T cell T cells vaccination Vaccine Vulnerable populations were assessed [DOI] 10.1093/cid/ciac408 PMC 바로가기 [Article Type] Article
COVID-19 mRNA Vaccines May Cause False Reactivity in Some Serologic Laboratory Tests, Including Rapid Plasma Reagin TestsCOVID-19 mRNA 백신은 Rapid Plasma Reagin 테스트를 포함한 일부 혈청학적 실험실 테스트에서 잘못된 반응성을 유발할 수 있음Article Published on 2022-08-042022-09-12 Journal: American journal of clinical pathology [Category] 진단, [키워드] assays baseline cause clinical picture Cohort coronavirus disease Course COVID-19 COVID-19 vaccination COVID-19 vaccine demonstrated determine Effect False positivity had no IgG Immunoglobulin incidence Including Infectious disease longitudinal study marker Messenger RNA Moderna MOST mRNA participant Participants Pfizer plasma prevaccination Rapid reactive reactivity reagin repeated RPR sera serologic serologic assay serologic assays serology shown susceptible syndrome Test tested vaccination Vaccine vaccine dose Variability viral infection virus [DOI] 10.1093/ajcp/aqac025 PMC 바로가기 [Article Type] Article
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans미국 참전용사를 대상으로 실시한 대조 테스트 음성 사례 대조 연구에서 오미크론 및 델타 변이체에 대한 mRNA COVID-19 백신의 효과Article Published on 2022-08-032022-09-11 Journal: BMJ Open [Category] SARS, 변종, [키워드] 95% CI Against Antigen booster booster dose booster doses booster vaccination case-control study Comorbidities conducted death Delta delta variant dose effective Effectiveness Electronic health record Epidemiology Health health administration health record hospitalisation immunology Infection male Messenger RNA mRNA mRNA COVID-19 vaccine mRNA vaccine mRNA vaccines Older omicron outcome positive result public health SARS-CoV-2 PCR SARS-CoV-2 test SARS-CoV-2 variant severe disease Symptoms the vaccine vaccination vaccinee vaccinees variant variants veteran [DOI] 10.1136/bmjopen-2022-063935 PMC 바로가기 [Article Type] Article
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2SARS-CoV-2에 의한 미래 감염에 대한 자연 감염 및 백신 유도 면역의 내구성Comparative Study Published on 2022-08-022022-09-12 Journal: Proceedings of the National Academy of Sciences of [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Ad26.COV2.S Analysis anti-S IgG antibody Antibody Response applied BNT162b2 booster vaccination Breakthrough infection ChAdOx1 conditions COVID-19 distribution elicited Endemic evaluated exceeded expected future infection IgG Immunity Immunoglobulin Infection knowledge likelihood median Messenger RNA Moderna mRNA mRNA-1273 natural infection Oxford-AstraZeneca pandemic parameter peak Pfizer-BioNTech public health Quantitative relative SARS-CoV-2 trajectory vaccination Vaccine Vaccine-induced immunity vaccine-mediated immunity Viral vector vaccine [DOI] 10.1073/pnas.2204336119 PMC 바로가기 [Article Type] Comparative Study
Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients중증급성호흡기증후군 코로나바이러스 2 간 이식 환자에서 동종 메신저 RNA 백신 3차 접종에 대한 항체 반응Article Published on 2022-08-012022-09-12 Journal: Liver transplantation : official publication of th [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome Antibody Response coronavirus dose homologous Liver transplantation Messenger RNA recipient vaccination [DOI] 10.1002/lt.26472 PMC 바로가기 [Article Type] Article
Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants유아의 SARS-CoV-2 감염 발생률과 임신 중 COVID-19 예방 접종의 연관성Article Published on 2022-08-012022-09-11 Journal: JAMA Internal Medicine [Category] Fulltext, SARS, 변종, [키워드] 95% CI adjusted hazard ratio age Birth Chain Reaction cohort study country COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Cox proportional hazard regression Delta delta variant determine dose during pregnancy Follow-up hazard ratio incidence rate Infant Infants life lower risk Maternal maternal age Messenger RNA mother Norway omicron Omicron variant outcome parity polymerase chain polymerase chain reaction population-based cohort positive Positive test Pregnancy pregnant women provide receive reduce reduced risk residence risk SARS-CoV-2 severe COVID-19 stratified suggested test result vaccination Vaccination Status variant variants was used women [DOI] 10.1001/jamainternmed.2022.2442 PMC 바로가기 [Article Type] Article